We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.

Schedule an appointment today

Find University Hospitals Doctors

Pedro Barata, MD

Pedro Barata, MD



41 Ratings 4 Reviews


Hematology and Oncology

Accepting New Patients

Primary Location

UH Cleveland Medical Center
11100 Euclid Ave
Cleveland, OH 44106

Schedule an Appointment



  • Director, Clinical Genitourinary Medical Oncology Research Program, UH Seidman Cancer Center

Pedro C. Barata, MD, MSc is a board-certified, fellowship-trained medical oncologist at University Hospitals Seidman Cancer Center and an Associate Professor of Medicine at Case Western Reserve University School of Medicine. His special clinical interests include kidney, prostate and bladder cancers.

Dr. Barata is also a renowned clinical trialist and researcher and serves as Director of the Clinical Genitourinary Medical Oncology Research Program at University Hospitals Seidman Cancer Center. His research interests include experimental therapeutics, the molecular profiling of tumors and genomic-based therapies for genitourinary tumors.

After completing his fellowship in medical oncology, Dr. Barata came to the United States in 2016 where he completed a clinical fellowship in experimental therapeutics in genitourinary tumors at the Cleveland Clinic Taussig Cancer Center in Cleveland, Ohio. During that time, he also rotated at the phase I / Experimental Therapeutics Department at MD Anderson Cancer Center, Houston, Texas.

Dr. Barata is an active member in numerous professional committees and societies, including the American Urological Association, the American Society of Clinical Oncology, the American Association for Cancer Research and the Society for Immunotherapy of Cancer.

The recipient of numerous research and education grants, Dr. Barata is a prolific author and co-author, with dozens of published studies and citations to his credit. Most recently, he was named as the Associate Editor of the ASCO Educational Book, an annual publication that serves to educate all members of the oncology care team on practice-changing oncology research so patients can receive the highest-quality, equitable care. Topics for the peer-reviewed articles are selected by ASCO’s Annual Meeting Education Committee and authored by the Annual Meeting Education Program faculty and international experts in oncology. Dr. Barata also serves as the Prostate Cancer Section Editor for the Oncologist journal and is a member of the editorial team of the Translational Oncology journal.


  • Clinical Research
  • Experimental Therapeutics
  • GU Medical Oncology
  • Kidney Cancer
  • Prostate Cancer


Watch to find out more about this University Hospitals provider.

Languages Spoken

English, Portuguese, Spanish

Office Locations

UH Cleveland Medical Center

11100 Euclid Ave
Cleveland, OH 44106

UH Minoff Health Center at Chagrin Highlands

3909 Orange Pl
Suite: 1100
Beachwood, OH 44122

SCC 3909 Orange

3909 Orange Pl
Suite: 4600
Orange, OH 44122

UH Minoff Health Center at Chagrin Highlands

3909 Orange Pl
Suite: 1100
Orange, OH 44122

Patient Experience Reviews

4.8 out of 5

41 Ratings

Patient Comments (4)

Reviewed On 8/1/2023
Always have had excellent encounters with UH staff, doctors, and nurses.

Reviewed On 8/1/2023
Dr Barata was caring, thoughtful and professional

Reviewed On 5/1/2023
Very Good Doctor

Reviewed On 4/1/2023
Excellent Dr.!

Research & Publications

Research Links

Certifications & Memberships

  • Internal Medicine - American Board of Internal Medicine


Fellowship | Experimental Therapeutics
Experimental Therapeutics - Cleveland Clinic - Taussig Cancer Center (2016 - 2018)

Fellowship | Medical Oncology
Medical Oncology - Alameda Santo Antonio Dos Capuchos (2013 - 2016)

Other Education
University Of Lisbon, Faculty Of Medicine (2015)

Medical Education
Nova Medical School (2009)

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Pedro Barata did not disclose any Outside Relationships with Industry.